Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
2026-10-08
|
5-day change | 1st Jan Change | ||
| 9.750 CNY | -1.02% |
|
-1.02% | -17.30% |
| Market Cap | 12.88B 1.92B 1.72B 1.6B 1.45B 2.74B 186B 2.76B 19.22B 7.52B 94.55B 7.21B 7.06B 304B | P/E 2026 * |
19.5x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 10.55B 1.57B 1.4B 1.31B 1.19B 2.24B 152B 2.26B 15.73B 6.15B 77.4B 5.91B 5.78B 249B | EV / Sales 2026 * |
2.07x | EV / Sales 2027 * | 2.47x |
| Free-Float |
14.94% | Yield 2026 * |
0.62% | Yield 2027 * | 0.72% |
| 1 day | -1.02% | ||
| 1 week | -1.02% | ||
| Current month | -1.02% | ||
| 1 month | -0.91% | ||
| 3 months | +4.28% | ||
| 6 months | -14.40% | ||
| Current year | -17.30% |
| 1 week | 9.7 |  | 10 |
| 1 month | 9.29 | | 10.02 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 12.68 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 1998-04-20 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 1998-04-20 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 2023-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 1998-04-20 |
Li Li
CHM | Chairman | 62 | 1998-04-20 |
Yu Shan
BRD | Director/Board Member | 65 | 1998-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/23 | Sell | 11,200 | 0.0009% | |||
| 5/26/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | -1.02% | -18.48% | -20.73% | 1.94B | |
| -2.55% | +0.50% | +36.63% | +102.10% | 1,060B | |
| -0.71% | -1.25% | +34.66% | +61.11% | 623B | |
| -0.11% | +3.98% | +16.88% | +81.26% | 480B | |
| -0.60% | -1.76% | +63.52% | +35.20% | 352B | |
| -2.03% | +1.06% | +21.08% | +40.60% | 345B | |
| -1.92% | -0.29% | +10.54% | +33.58% | 274B | |
| -2.36% | -1.16% | -7.14% | +9.54% | 249B | |
| -1.60% | -0.51% | +37.53% | +49.22% | 223B | |
| +0.11% | -0.82% | +23.71% | +94.90% | 182B | |
| Average | -1.29% | -0.26% | +21.89% | +48.68% | 378.99B | |
| Weighted average by Cap. | -1.48% | +0.04% | +29.53% | +66.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.1B 761M 680M 634M 576M 1.08B 73.72B 1.09B 7.61B 2.98B 37.46B 2.86B 2.8B 120B | 5.62B 837M 748M 698M 634M 1.19B 81.11B 1.2B 8.38B 3.28B 41.21B 3.14B 3.08B 133B |
| Net income | 731M 109M 97.29M 90.76M 82.44M 155M 10.55B 157M 1.09B 426M 5.36B 409M 400M 17.24B | 874M 130M 116M 109M 98.6M 186M 12.62B 187M 1.3B 510M 6.41B 489M 479M 20.62B |
| Net Debt | -2.34B -349M -311M -290M -264M -496M -33.75B -501M -3.49B -1.36B -17.15B -1.31B -1.28B -55.16B | 1B 150M 134M 125M 113M 213M 14.5B 215M 1.5B 586M 7.37B 562M 550M 23.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | CN¥9.750 | -1.02% | 4,326,820 |
| 26-09-30 | CN¥9.850 | +2.50% | 4,148,623 |
| 26-09-29 | CN¥9.610 | -0.52% | 2,899,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
